Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Finance and funding news

Show

From To
First long-term study finds half trillion dollars spent on HIV/AIDS

Spending on HIV/AIDS globally between 2000 and 2015 totaled more than half a trillion dollars, according to a new scientific study, the first comprehensive analysis of funding for the disease. The total was $562.6 billion over the 16-year period. Annual spending peaked in 2013 with $49.7 billion. Two years later, $48.9 billion was provided for the care, treatment, and prevention of the disease.

Published
18 April 2018
From
EurekAlert (press release)
PEPFAR highlights gains and accountability, while treatment advocates highlight “Deadly Impact” of policy, funding gaps

The United States President’s Emergency Plan for AIDS Relief today released its 14th Annual Report to Congress, highlighting advances against HIV globally. It leaves open questions about the eventual success of a program facing persisting challenges of unmet needs, a population explosion among those at greatest risks, flat budget allocations, an unprecedentedly restrictive “Mexico City” policy, and the continued threat of radical funding cuts.

Published
11 April 2018
From
Science Speaks
Has Basic Science in HIV Research Stalled?

Now that effective therapies for active HIV infection are broadly available, there should be renewed focus on basic science regarding HIV, said experts contacted by MedPage Today.

Published
09 April 2018
From
MedPage Today
Better ways to combat HIV than seeking a vaccine

Are human-vaccine trials the best use of resources? Based on the current reality, HIV treatment and prevention strategies that have been proven to work would be a much better use of the millions of dollars being spent on the large-scale vaccine clinical trials.

Published
22 March 2018
From
Business Day
More than 200 Scientists, Researchers and Clinicians including the co-discoverer of HIV Denounce Trump Administration Policies that Undermine the Global HIV Response

More than 200 HIV scientists, researchers and clinicians – including Françoise Barré-Sinoussi, a virologist and Nobel Laureate who co-discovered HIV; Linda-Gail Bekker, President of the International AIDS Society; and the HIV Medicine Association – have signed an open letter to U.S. President Donald Trump denouncing the deterioration of evidence-based policymaking during his administration. The letter was released today on the final day of the annual Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, Massachusetts.

Published
08 March 2018
From
Health Gap
In the Era of Daily PrEP, Feds May Stop Research Funding Gels, Rings, and Douches for HIV Prevention

It's precisely because of the overwhelming success in recent years of oral PrEP that the future of the anal douche and other sorts of topically applied anti-HIV agents, such as gels and dissolvable films, all loosely termed "microbicides," is suddenly up in the air, if not outright doomed.

Published
07 March 2018
From
The Body
Groups working to end AIDS fear losing ground under Trump

Advocates working to end the AIDS epidemic fear they may lose ground under the Trump administration after coming within reach of ending the disease’s siege in the U.S. and abroad.

Published
28 February 2018
From
The Hill
Beyond donor dollars for health care: how Uganda is thinking outside the box

What’s become increasingly clear is that there’s funding gap for the scale-up of antiretroviral treatment as well as service delivery. In our research we looked at how Uganda is attempting to plug this gap with a range of innovative approaches involving different donors and for different aspects of HIV treatment.

Published
23 February 2018
From
The Conversation
Michel Kazatchkine: Winds of hope on HIV/AIDS in Eastern Europe and Central Asia?

Much of the media coverage focused on the intransigence of the government of the Russian Federation to changing its prevention policies around HIV/AIDS. However, this focus also obscures the fact that in Eastern Europe and Central Asia which has been much maligned over the past decade for its slowness in responding to the HIV/AIDS epidemic, we are now beginning to see strong hints that public health initiatives based on scientific evidence are taking on a legitimacy across the region.

Published
20 February 2018
From
BMJ
How both sides in Ukraine's war are losing the HIV battle

Displacement, aid delivery issues, and different strategies are all feeding a raging epidemic.

Published
16 February 2018
From
IRINnews.org
← First12345...97Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.